Skip to main content
Clinical Trials/NCT01319292
NCT01319292
Completed
Not Applicable

To Investigate the Prevalence of Children Asthma in China and Compare With That of the Last 20 Years

Capital Institute of Pediatrics, China0 sites20,000 target enrollmentApril 2011
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Capital Institute of Pediatrics, China
Enrollment
20000
Primary Endpoint
prevalence of asthma
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Asthma is the most common chronic respiratory disease in children and has much effect on their life and study, which leads to huge economic burden and pressure to the whole families. Some children will develop into adult patients so that asthma can be the life-long vigorous trouble. In recent years, the prevalence rate of children asthma is increasingly going up worldwide. The prevalence rate in last 12 months reported in USA, United Kingdom, Australia, New Zealand was between 12% to 30%.

Center for Asthma Prevention and Education of Capital Institute of Pediatrics investigated the national asthma prevalence in 900 thousands children in 27 provinces and cities, which average rate was 0.11% to 2.03% in 1990. In 2000, we investigated it again in 31 provinces(43 cities) and the average national children asthma prevalence rate was 1.97%(0.25% to 4.63%) which was much higher than that in 1990.

Detailed Description

1. Objectives 1. To investigate the national children(0-14 years old)asthma prevalence; 2. To compare the prevalence rate between that in 1990 and 2000; 3. To analyse the asthma manifestations including the ages, seasons, causes, trigger and hereditary factors and their impact on the asthma patients, families and society; 4. To identify the risk factors by questionnaires in case-control research. 2. Study Design / Clinical Plan 1. The screening stage: to distinguish suspected asthma from the children age from 0 to 14 years old. 2. To obtain identified asthma from the suspected asthma. 3. To evaluate the prevalence and severe degree of 0 to 14-year-old children asthma and gain the main risk factors by case-control research.

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
April 2014
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Capital Institute of Pediatrics, China
Responsible Party
Principal Investigator
Principal Investigator

Chen Yuzhi

Professor

Capital Institute of Pediatrics, China

Eligibility Criteria

Inclusion Criteria

  • children age from 0 to 14 years

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

prevalence of asthma

Time Frame: Apr 2013

Secondary Outcomes

  • prevalence of allergic rhinitis(Apr 2013)

Similar Trials